BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9042576)

  • 1. Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice.
    Airaksinen MS; Thoenen H; Meyer M
    Eur J Neurosci; 1997 Jan; 9(1):120-7. PubMed ID: 9042576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice.
    Gaspar P; Ben Jelloun N; Febvret A
    Neuroscience; 1994 Jul; 61(2):293-305. PubMed ID: 7969910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration.
    Liang CL; Sinton CM; Sonsalla PK; German DC
    Neurodegeneration; 1996 Dec; 5(4):313-8. PubMed ID: 9117542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene.
    Airaksinen MS; Eilers J; Garaschuk O; Thoenen H; Konnerth A; Meyer M
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1488-93. PubMed ID: 9037080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.
    German DC; Manaye KF; Sonsalla PK; Brooks BA
    Ann N Y Acad Sci; 1992 May; 648():42-62. PubMed ID: 1353337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin.
    Liang CL; Sinton CM; German DC
    Neuroscience; 1996 Nov; 75(2):523-33. PubMed ID: 8931015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP.
    Sanghera MK; Manaye K; McMahon A; Sonsalla PK; German DC
    Neuroreport; 1997 Oct; 8(15):3327-31. PubMed ID: 9351666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.
    McCormack AL; Atienza JG; Langston JW; Di Monte DA
    Neuroscience; 2006 Aug; 141(2):929-937. PubMed ID: 16677770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotoxin MPTP increases calbindin-D28k levels in mouse midbrain dopaminergic neurons.
    Ng MC; Iacopino AM; Quintero EM; Marches F; Sonsalla PK; Liang CL; Speciale SG; German DC
    Brain Res Mol Brain Res; 1996 Mar; 36(2):329-36. PubMed ID: 8965654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulnerability to excitotoxic stimuli of cultured rat hippocampal neurons containing the calcium-binding proteins calretinin and calbindin D28K.
    Möckel V; Fischer G
    Brain Res; 1994 Jun; 648(1):109-20. PubMed ID: 7922513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calbindin-D28k-containing neurons in the human hypothalamus: relationship to dopaminergic neurons.
    Sanghera MK; Zamora JL; German DC
    Neurodegeneration; 1995 Dec; 4(4):375-81. PubMed ID: 8846230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroactive peptides exist in the midbrain dopaminergic neurons that contain calbindin-D28k.
    German DC; Liang CL
    Neuroreport; 1993 May; 4(5):491-4. PubMed ID: 8513124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calbindin-D28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity.
    Iacopino A; Christakos S; German D; Sonsalla PK; Altar CA
    Brain Res Mol Brain Res; 1992 Apr; 13(3):251-61. PubMed ID: 1317497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration- and cell type-specific effects of calbindin D28k on vulnerability of hippocampal neurons to seizure-induced injury.
    Gary DS; Sooy K; Chan SL; Christakos S; Mattson MP
    Brain Res Mol Brain Res; 2000 Jan; 75(1):89-95. PubMed ID: 10648891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The weaver mouse gain-of-function phenotype of dopaminergic midbrain neurons is determined by coactivation of wvGirk2 and K-ATP channels.
    Liss B; Neu A; Roeper J
    J Neurosci; 1999 Oct; 19(20):8839-48. PubMed ID: 10516303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dopamine transporter mRNA levels in midbrain regions containing calbindin.
    Sanghera MK; Manaye KF; Liang CL; Lacopino AM; Bannon MJ; German DC
    Neuroreport; 1994 Aug; 5(13):1641-4. PubMed ID: 7819538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calbindin-D28k in nerve cell nuclei.
    German DC; Ng MC; Liang CL; McMahon A; Iacopino AM
    Neuroscience; 1997 Dec; 81(3):735-43. PubMed ID: 9316025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efferent synaptic connections of dopaminergic neurons grafted into the caudate nucleus of experimentally induced parkinsonian monkeys are different from those of control animals.
    Leranth C; Sladek JR; Roth RH; Redmond DE
    Exp Brain Res; 1998 Dec; 123(3):323-33. PubMed ID: 9860271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cell line-derived neurotrophic factor protects midbrain dopamine neurons from the lethal action of the weaver gene: a quantitative immunocytochemical study.
    Broome JD; Wills KV; Lapchak PA; Ghetti B; Camp LL; Bayer SA
    Brain Res Dev Brain Res; 1999 Aug; 116(1):1-7. PubMed ID: 10446341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.
    Lavoie B; Parent A
    Neuroreport; 1991 Oct; 2(10):601-4. PubMed ID: 1684519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.